Treatment of Uncomplicated P. falciparum Malaria in First-Trimester Pregnancy

Clinical Scenario

This protocol applies to patients who are in the first trimester of pregnancy and present with uncomplicated Plasmodium falciparum malaria. Early pregnancy introduces specific constraints on treatment selection that distinguish this population from non-pregnant patients.

Treatment Approach

Management centres on an artemisinin-based combination therapy (ACT) chosen for its suitability in early pregnancy — not all ACTs are appropriate in this trimester, and the selection follows specific criteria laid out in the full protocol.

The complete regimen — preferred agent, alternatives by availability, and contraindicated combinations — is available in the structured protocol below.

Treatment Goal

The clinical aim is elimination of all parasites from the body, with resolution of fever and parasitaemia.

Instant Access to Structured Evidence-Based Regimens

References

Pregnant women with uncomplicated P. falciparum malaria should be treated with artemether-lumefantrine during the first trimester.

Antifolates are contraindicated in the first trimester of pregnancy. Therefore, ACTs containing sulfadoxine-pyrimethamine are contraindicated during the first trimester of pregnancy.

“Cure” is defined as elimination of all parasites from the body.

View source ↗